Ozone treatment for bladder pain syndrome
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests ozone therapy placed directly into the bladder to help with the pain and discomfort of interstitial cystitis (also called bladder pain syndrome). It may be an option for people who have had symptoms for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with interstitial cystitis / bladder pain syndrome (confirmed by a doctor).
- Your symptoms have lasted for at least 6 months.
- You do not have a current bladder infection or bladder cancer.
- You are not pregnant, breastfeeding, or allergic to ozone.
- You have not had bladder treatments (medication put directly into the bladder) in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture can help relieve pain and pressure from bladder pain syndrome (also called interstitial cystitis). Researchers want to see if using acupuncture early can improve symptoms better than usual care.
This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.
This trial tests whether peppermint oil can reduce symptoms of interstitial cystitis (also called bladder pain syndrome). It’s mainly looking at safety and early signs it may help your bladder discomfort.
This study tests a new treatment (VNX001) for people with interstitial cystitis or bladder pain syndrome (IC/BPS). You must have already taken part in an earlier study of this drug to join. The goal is to see if it safely reduces bladder pain.
This trial tests a treatment made from amniotic membrane (a natural tissue) to help reduce pain and discomfort in people with Interstitial Cystitis (also called Painful Bladder Syndrome). It is for women who have tried at least one other treatment without success.
This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.
Hear when a new Interstitial Cystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.